Actualités Abbvie CDR - ABBV | Actions NEO Exchange | ADVFN

Inscrivez-vous pour des graphiques en temps réel, des outils d'analyse et des prix.

S'inscrire

Accueil
Investir
Actions
Canadá
NEO
Abbvie CDR (ABBV)
Abbvie CDR (ABBV) Actualités

Abbvie CDR (ABBV)

30,86

0,56

(1,85%)

Fermé 09 Mars 9:00PM

Données en temps réel

Discussions et idées de trading en temps réel : négociez en toute confiance avec notre puissante plateforme.

Form 4 - Statement of changes in beneficial ownership of securities

Form 4 - Statement of changes in beneficial ownership of securities

Form 4 - Statement of changes in beneficial ownership of securities

Form 4 - Statement of changes in beneficial ownership of securities

Form 4 - Statement of changes in beneficial ownership of securities

AbbVie to Present at the Leerink Partners Global Healthcare Conference

AbbVie to Present at the Leerink Partners Global Healthcare Conference PR Newswire NORTH CHICAGO, Ill., March...

Form 144 - Report of proposed sale of securities

AbbVie and Gubra Announce License Agreement to Develop an Amylin Analog for the Treatment of Obesity

AbbVie and Gubra Announce License Agreement to Develop an Amylin Analog for the Treatment of Obesity PR...

Form 4 - Statement of changes in beneficial ownership of securities

Form 4 - Statement of changes in beneficial ownership of securities

Form 144 - Report of proposed sale of securities

AbbVie Receives Positive CHMP Opinion for Upadacitinib (RINVOQ®) for the Treatment of Adults with Giant Cell Arteritis

AbbVie Receives Positive CHMP Opinion for Upadacitinib (RINVOQ®) for the Treatment of Adults with Giant Cell...

Form 144 - Report of proposed sale of securities

Forums

Afficher les forums

Aucune Discussion Trouvée

Ajouter une Discussion

Portugal Tf 1% Ap52 Eur

Vontobel Financial Produ...

Delayed Upgrade Clock

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales